Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies113
Primer Capital
Primer Capital is a venture capital firm in Moscow City that focuses on investing in biotech and medical companies.
Sector
Subsector
Keywords
Location
count Of Investments
venBio Partners
venBio is a life sciences investment firm that partners with industry leaders to develop groundbreaking medicines.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
RusnanoMedInvest
RusnanoMedInvest is a Moscow-based venture capital firm specializing in innovative developments in pharmaceuticals and biotechnology.
Sector
Subsector
Location
count Of Investments
count Of Exists
EFung Capital
Shenzhen EFUNG Investment Management Enterprise is a pioneering VC institution that invests in professional biomedical industries.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Financials
Investments24
Brenig Therapeutics
Brenig Therapeutics develops therapies for neurodegenerative disorders.
total rounds
total raised
i2020 Accelerator
The i2020 Accelerator offers funding and resources to companies focusing on inflammation, oncology, CNS, and infectious diseases.
Sector
Subsector
total rounds
Context Therapeutics
Context Therapeutics develops advanced treatments for women's hormone-driven cancers.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits1
Tensha Therapeutics
Tensha Therapeutics is a biotech company developing small molecule bromodomain inhibitors to treat cancer and other serious disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders1
Nikolay Savchuk
Nikolay Savchuk Ph.D. is a serial entrepreneur and experienced international investor in the healthcare and IT industries for 23 years. Dr. Savchuk is the co-founder and Managing Partner at San Diego-based Torrey Pines Investment LLC, CEO of ChemDiv, a member of the Board of ChemRar High Tech Center, ChemRar Ventures, and the chairman of the board of directors of its companies: Chemical Diversity Research Institute, Viriom, NewVac, TeaRx, and SatRx. Dr. Savchuk also serves as co-chair of the Joint Investment Committees between ChemRar Ventures and JJDC as well as Torrey Pines Investment and BioMotiv. Dr. Savchuk is a member of U.S.-Russian Bilateral Presidential Commission’s Working Group on Health, a member of the expert council of the Agency of Strategic Initiatives and New Projects of the Russian government, member on the board of the non-profit BioPharmCluster Northern, co-founder and member of the advisory board Initiative “PhysTech 21″, and the Director for Strategic Development of the Moscow Institute of Physics and Technology (MIPT). Dr. Savchuk was a co-founder of the Inel Group of IT and media companies in Singapore and Russia and managed several of its companies. The scope of main interest of Dr. Savchuk is life sciences including rational drug design, drug discovery and digital health technologies. Dr. Savchuk led and continues to manage successful investments in pharmaceutical and drug development companies. Dr. Savchuk obtained the MS degree in physics in 1994 and Ph.D. in applied mathematics in 2000 from Moscow Institute of Physics and Technology. He is an inventor and author of over 100 patents and research publications.
current job
organization founded
Nikolay Savchuk
